Differences in State Drug Testing and Reporting by Driver Type in U.S. Fatal Traffic Crashes

Megan E. Slatera, I-Jen P. Castlea, Barry K. Loganb, Ralph W. Hingsonc

aCSR, Incorporated, 4250 Fairfax Drive, Suite 500, Arlington, VA 22203, United States, bNMS Labs, 3701 Welsh Road, Willow Grove, PA 19090, United States, cNational Institute on Alcohol Abuse and Alcoholism, 5635 Fishers LN, Rockville, MD 20852, United States

 

The article Differences in State Drug Testing and Reporting by Driver Type in U.S. Fatal Traffic Crashes appears in Accident Analysis and Prevention 92 (2016) 122–129. Abstract is included below.

Please e-mail us if you would like a PDF copy of the published article.

ABSTRACT: Introduction: Driving under the influence of drugs, including marijuana, has become more prevalent in recent years despite local, state, and federal efforts to prevent such increases. The Fatality Analysis Reporting System (FARS) is the primary source of drugged driving data for fatal crashes in the United States but lacks the completeness required to calculate unbiased estimates of drug use among drivers involved in fatal crashes.
Methods: This article uses the 2013 FARS dataset to present differences in state drug testing rates by driver type, driver fault type, and state-level factors; discusses limitations related to analysis and interpretation of drugged driving data; and offers suggestions for improvements that may enable appropriate use of FARS drug testing data in the future. 
Results: Results showed that state drug testing rates were highest among drivers who died at the scene of the crash (median = 70.8%) and drivers who died and were at fault in the crash (median = 64.4%). The lowest testing rates were seen among surviving drivers who were not transported to a hospital (median = 14.0%) and surviving drivers who were not at fault in the crash (median = 10.0%). Drug testing rates differed by state blood alcohol content (BAC) testing rate across all driver types and driver fault types, and in general, states that tested a higher percentage of drivers for BAC had higher drug testing rates.
Discussion: Testing rates might be increased through standardization and mandatory testing policies. FARS data users should continue to be cautious about the limitations of using currently available data to quantify drugged driving. More efforts are needed to improve drug testing and reporting practices, and more research is warranted to establish drug concentration levels at which driving skills become impaired.

NMS Labs is the only independent forensic facility in the nation to be certified by both the ABFT (American Board of Forensic Toxicology) and ANAB-ASCLD/LAB-International (ANSI/ASQ National Accreditation Board-American Society of Crime Lab Directors/Lab Accreditation Board ISO 17025). ISO 17025 accreditation covers the disciplines of Toxicology, DNA, serology and controlled substances. We diligently maintain and exceed the high standards set by these organizations, so that you can have the utmost confidence in your testing results.